New insider filings for BPAX: BIOSANTE PHARMACEUTICALS INC Senior Officer (Sr VP of Finance, CFO, Secy): DONENBERG PHILIP B Acquired 285,000 Employee Stock Option (right to buy) (Derivative security at conversion or exercise price: $0.684) on Jan 25, 12. Direct holding 285,000 shares/units after transaction. Employee Stock Option (right to buy) expires on Jan 24, 22. First-Class Insider (Vice Chairman, President & CEO): SIMES STEPHEN M Acquired 800,000 Employee Stock Option (right to buy) (Derivative security at conversion or exercise price: $0.684) on Jan 25, 12. Direct holding 800,000 shares/units after transaction. Employee Stock Option (right to buy) expires on Jan 24, 22. Senior Officer (Sr. VP of Medical Affairs): Snabes Michael C Acquired 165,000 Employee Stock Option (right to buy) (Derivative security at conversion or exercise price: $0.684) on Jan 25, 12. Direct holding 165,000 shares/units after transaction. Employee Stock Option (right to buy) expires on Jan 24, 22.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.